Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells

STAR Protocols(2020)10.1016/j.xpro.2020.100113Source: DataRank Database

CRISPR-Cas9 Ribonucleoprotein-Mediated Genomic Editing in Primary Innate Immune Cells is a research paper published in STAR Protocols (2020). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.60)OA: goldTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Luke Riggan ORCID,Timothy E. O’Sullivan ORCID,Andrew D. Hildreth ORCID

Live enrichment

PubMed:33377009 PMC:PMC7756923 OpenAlex:https://openalex.org/W3091902158

National Institutes of Health

Grant: AI145997

National Institutes of Health

Grant: P30DK063491

NIAID NIH HHS

Grant: R01 AI145997

NIAID NIH HHS

Grant: T32 AI007323

National Institutes of Health

Grant: 3P30DK063491-04S1

Diabetes Endocrinology Research Center

National Institutes of Health

Grant: 5R01AI145997-05

Transcriptional mechanisms of natural killer cell responses during mouse cytomegalovirus infection

FWCI

0.60

Citation Percentile

0.6%

Citation Trend

2021

2022

2023

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.xpro.2020.100113

publisherhttps://doi.org/10.1016/j.xpro.2020.100113

publisherhttps://api.elsevier.com/content/article/PII:S2666166720301003?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666166720301003?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33377009

Fields of Study

CRISPR and Genetic EngineeringCAR-T cell therapy researchViral Infections and Immunology Research0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Gene EditingAnimalsHumansImmunity, InnateLymphocytesRibonucleoproteinsElectroporationMyeloid CellsGenomicsCRISPR-Cas Systems

Keywords

Genome editingCRISPRInnate immune systemBiologyCas9RibonucleoproteinComputational biologyAcquired immune systemLimitingGenomeElectroporationGeneImmune systemGeneticsRNAGene EditingScience (General)GenomicsImmunity, InnateQ1-390RibonucleoproteinsProtocolAnimalsHumansMyeloid CellsLymphocytesCRISPR-Cas Systems

Sustainable Development Goals

SDG 3: 3. Good health